LUNG Covered Call Strategy
LUNG (Pulmonx Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Platform, a cloud-based service that conducts quantitative computed tomography (CT) analysis. This platform delivers vital data concerning emphysema destruction, fissure completeness, and lobar volume, thereby aiding clinicians in accurately identifying the most suitable target lobes for treatment with Zephyr Valves.
LUNG (Pulmonx Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $96.7M, a beta of 0.29 versus the broader market, a 52-week range of 1.13-2.89, average daily share volume of 516K, a public-listing history dating back to 2020, approximately 296 full-time employees. These structural characteristics shape how LUNG stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.29 indicates LUNG has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on LUNG?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
LUNG snapshot
As of August 14, 2026, spot at $2.40, ATM IV 144.70%, IV rank 32.85%, expected move 41.48%. The covered call on LUNG below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on LUNG specifically: LUNG IV at 144.70% is mid-range versus its 1-year history, so the credit collected on a LUNG covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 41.48% (roughly $1.00 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LUNG expiries trade a higher absolute premium for lower per-day decay. Position sizing on LUNG should anchor to the underlying notional of $2.40 per share and to the trader's directional view on LUNG stock.
LUNG covered call setup
The LUNG covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LUNG at $2.40 on that close, the first option leg uses a $2.52 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LUNG chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LUNG shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $2.40 | long |
| Sell 1 | Call | $2.52 | N/A |
LUNG covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
LUNG covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on LUNG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on LUNG
Covered calls on LUNG are an income strategy run on existing LUNG stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
LUNG thesis for this covered call
The market-implied 1-standard-deviation range for LUNG extends from approximately $1.40 on the downside to $3.40 on the upside. A LUNG covered call collects premium on an existing long LUNG position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether LUNG will breach that level within the expiration window. Current LUNG IV rank near 32.85% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on LUNG should anchor more to the directional view and the expected-move geometry. As a Healthcare name, LUNG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LUNG-specific events.
LUNG covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LUNG positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LUNG alongside the broader basket even when LUNG-specific fundamentals are unchanged. Short-premium structures like a covered call on LUNG carry tail risk when realized volatility exceeds the implied move; review historical LUNG earnings reactions and macro stress periods before sizing. Always rebuild the position from current LUNG chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on LUNG?
- A covered call on LUNG is the covered call strategy applied to LUNG (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With LUNG stock at $2.40 on the most recent close, the strikes shown on this page are snapped to the nearest listed LUNG chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are LUNG covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the LUNG covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 144.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LUNG covered call?
- The breakeven for the LUNG covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LUNG market-implied 1-standard-deviation expected move in the same options snapshot is approximately 41.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on LUNG?
- Covered calls on LUNG are an income strategy run on existing LUNG stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current LUNG implied volatility affect this covered call?
- LUNG ATM IV is at 144.70% with IV rank near 32.85%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.